
Prime Medicine Stock Hits Day Low of $4.45 Amid Price Pressure
2025-11-04 18:37:23Prime Medicine, Inc. has faced a significant stock decline, with a notable drop in both weekly and monthly performance. Despite reporting substantial growth in net sales, the company struggles with negative EBITDA and high operating cash flow losses. Its long-term performance reflects considerable volatility in the market.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






